# Occipital shuntalgia: Rethinking post-shunt occipital headache etiology and care

**Authors:** Shachar Zion Shemesh, Noa Rennert, Zeev Feldman, Paz Kelmer, Itay Goor-Aryeh, Oded Jacobi, Gabriel Lichtenstein, Yotam Hadari, Zvi R. Cohen, Lior Ungar

PMC · DOI: 10.1007/s00701-026-06797-4 · Acta Neurochirurgica · 2026-02-18

## TL;DR

Some post-shunt headaches are caused by nerve irritation from shunt hardware, not over-drainage, and respond better to nerve treatments than shunt revisions.

## Contribution

Identifies a new cause of post-shunt headache as occipital neuralgia, distinct from traditional causes like over-drainage.

## Key findings

- 1.08% of VP shunt patients developed occipital neuralgia-like headaches not due to shunt malfunction or over-drainage.
- Nerve-targeted therapies provided significant relief for these patients, unlike shunt-directed interventions.
- Clinical features included occipital-predominant pain and focal tenderness over the shunt valve or tract.

## Abstract

Headache after ventriculoperitoneal (VP) shunting is classically attributed to CSF over-drainage or shunt malfunction. We hypothesized that a subset of adults instead experience an occipital neuralgia-like pain syndrome (“Occipital Neuralgia”) from shunt hardware irritating the occipital nerves, and that these cases respond better to nerve-targeted treatments than to shunt revisions.

We retrospectively reviewed 2,223 adults who underwent first-time VP shunt placement between 2000 and 2025 at a tertiary center. Patients with post-shunt headache were identified and classified as Occipital Neuralgia if they had occipital-predominant, lancinating pain with focal tenderness over the valve or tract, short-term relief from diagnostic occipital nerve block, and no evidence of over-drainage, malfunction, or infection on work-up. Clinical features, management, and outcomes (nerve blocks, neuromodulation, shunt adjustments or revisions) were compared between Occipital Neuralgia and other post-shunt headaches.

Among 2,223 adults who underwent VP shunt placement, 32 patients (1.44%) developed new, persistent post-shunt headaches not attributable to shunt malfunction, over-drainage, or infection. Of these, 24 patients (1.08% of the total cohort; 75% of chronic post-shunt headaches) met criteria for Occipital Neuralgia. These patients typically presented with occipital-predominant, lancinating pain, focal scalp tenderness over the shunt valve or tract, and absence of orthostatic features. Neuroimaging demonstrated normal or slit ventricles without signs of intracranial hypotension or other structural intracranial pathology. Most patients experienced substantial symptomatic improvement following nerve-targeted therapies, whereas shunt-directed interventions provided limited benefit once pressure-related causes were excluded.

Post-shunt occipital neuralgia is a recognizable, under-appreciated cause of headache after VP shunting. Early recognition of a focal occipital neuropathic phenotype and nerve-targeted therapy can yield meaningful relief and help avoid unwarranted shunt revisions. Prospective validation of diagnostic criteria and management pathways is needed.

## Full-text entities

- **Diseases:** IIH (MESH:C566987), intracranial hypertension (MESH:D019586), chronic pain (MESH:D059350), intracranial hypotension (MESH:D019585), neuralgia (MESH:D009437), dysesthesias (MESH:D010292), nerve block (MESH:D006327), pain syndrome (MESH:C538101), neuropathic medications (MESH:D000069279), scalp tenderness (MESH:D063806), pressure abnormalities (MESH:D006610), VP shunts (MESH:C562451), Hydrocephalus (MESH:D006849), primary headache disorders (MESH:D051270), related (MESH:D019973), nerve (MESH:C537568), allodynia (MESH:D006930), migraine (MESH:D008881), neuralgic pain syndromes (MESH:D005157), fever (MESH:D005334), brain tumor-related hydrocephalus (MESH:D001932), NPH (MESH:D006850), Headache (MESH:D006261), inflammation (MESH:D007249), subdural hygromas (MESH:D013353), trauma (MESH:D014947), tension-type (MESH:D018781), hematomas (MESH:D006406), slit ventricle syndrome (MESH:D056124), CSF (MESH:D002559), ONB (MESH:D006259), Pain (MESH:D010146), fractures (MESH:D050723), entrapment neuropathy (MESH:D009408), subarachnoid hemorrhage (MESH:D013345), nerve irritation (MESH:D000080902), infection (MESH:D007239), aneurysmal or traumatic (MESH:D000783), shunt failure (MESH:D051437), tumor (MESH:D009369), congenital or post-infectious hydrocephalus (MESH:D000094025), vascular lesions (MESH:D014652), Headache Disorders (MESH:D020773), idiopathic intracranial hypertension (MESH:D011559), pleocytosis (MESH:D007964)
- **Chemicals:** steroid (MESH:D013256), VP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920730/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12920730/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920730/full.md

---
Source: https://tomesphere.com/paper/PMC12920730